Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Review

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results

       
Total article views   HTML views PDF downloads Totals
6,829 Dovepress* 6,829+ 1,678 8,507
Totals 6,829 1,678 8,507
*Since 8 February 2008
+Since July 2016

View citations on Google Scholar